Providing the right nutrition to critically ill patients who are unable to feed themselves, therefore needing artificial feeding, is a key part of their recovery, yet current methods rely on mathematical equations that often under- or overestimate calorie needs.

The QNRG+ Indirect Calorimetry Device offers a state-of-the-art solution, accurately measuring energy expenditure in critically ill patients by analysing oxygen consumption and carbon dioxide production to determine how many calories a patient burns per day. This allows clinicians to personalise nutrition based on real-time metabolic demands, ensuring patients receive the correct number of calories during their illness and recovery.

Critical illness leads to muscle breakdown, weakened immunity, and metabolic imbalances. Artificial nutrition is essential for ICU patients, but a “one-size-fits-all” approach is ineffective. Both underfeeding and overfeeding are linked to complications, longer ICU stays and increased mortality.

By using the QNRG+ device, medical staff can optimise feeding for the most complex patients, including those with sepsis, obesity, malnutrition, major surgery, or difficulty weaning from a ventilator. Use of the device reduces complications, shortens hospital stays, improves survival rates, and lowers healthcare costs by minimising nutrition-related issues.

HHFT will collect and analyse patient outcome data, using it for audits, regional teaching, research publications, and grant applications, further strengthening the hospital’s academic profile.

By integrating QNRG+ Indirect Calorimetry, HHFT would be ensuring every critically ill patient receives the optimal nutritional support needed for survival and recovery.